Trial Outcomes & Findings for A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease (NCT NCT03557086)

NCT ID: NCT03557086

Last Updated: 2024-03-18

Results Overview

The proposed video intervention will be deemed feasible if at least 60% of eligible patients are enrolled in the study.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

By 12 months

Results posted on

2024-03-18

Participant Flow

Participant milestones

Participant milestones
Measure
Advanced Care Planning Video Decision Support Tool
We designed a 3-minute advance care planning video to provide patients with advanced liver disease general understanding of the types of medical care patients may receive at the end of life (EOL) and a description of medical interventions such as hospitalizations, intensive care unit (ICU) admission, cardiopulmonary resuscitation (CPR), and intubation. The video begins by addressing the importance of the patient's personal goals and perspectives by asking the viewer to reflect on their concerns about getting sick and their overall goals for their EOL care. The physician narrator then introduces a framework for choices of medical care at the EOL including: 1) life-prolonging care; 2) limited medical care; and 3) comfort care followed by visual images illustrating each of these EOL care choices. All three sequences of video images accompanying the narration attempt to help the viewer imagine the experience and likely outcomes of receiving these medical interventions at the EOL. Advance Care Planning Video Decision Support Tool: Advance care planning video intervention as previously described
Verbal Narrative Control
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Overall Study
STARTED
26
24
Overall Study
COMPLETED
26
24
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Advanced Care Planning Video Decision Support Tool
n=26 Participants
We designed a 3-minute advance care planning video to provide patients with advanced liver disease general understanding of the types of medical care patients may receive at the end of life (EOL) and a description of medical interventions such as hospitalizations, intensive care unit (ICU) admission, cardiopulmonary resuscitation (CPR), and intubation. The video begins by addressing the importance of the patient's personal goals and perspectives by asking the viewer to reflect on their concerns about getting sick and their overall goals for their EOL care. The physician narrator then introduces a framework for choices of medical care at the EOL including: 1) life-prolonging care; 2) limited medical care; and 3) comfort care followed by visual images illustrating each of these EOL care choices. All three sequences of video images accompanying the narration attempt to help the viewer imagine the experience and likely outcomes of receiving these medical interventions at the EOL. Advance Care Planning Video Decision Support Tool: Advance care planning video intervention as previously described
Verbal Narrative Control
n=24 Participants
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Total
n=50 Participants
Total of all reporting groups
Age, Continuous
60.5 years
n=5 Participants
58.5 years
n=7 Participants
60 years
n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
12 Participants
n=7 Participants
25 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
12 Participants
n=7 Participants
25 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
n=5 Participants
24 Participants
n=7 Participants
49 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
White
24 Participants
n=5 Participants
24 Participants
n=7 Participants
48 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Education
Some high school
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Education
High school graduate
9 Participants
n=5 Participants
10 Participants
n=7 Participants
19 Participants
n=5 Participants
Education
Some college
4 Participants
n=5 Participants
6 Participants
n=7 Participants
10 Participants
n=5 Participants
Education
College graduate
9 Participants
n=5 Participants
5 Participants
n=7 Participants
14 Participants
n=5 Participants
Education
Postgraduate
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Education
Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Marital Status
Married or with a partner
17 Participants
n=5 Participants
14 Participants
n=7 Participants
31 Participants
n=5 Participants
Marital Status
Widowed
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Marital Status
Divorced
4 Participants
n=5 Participants
6 Participants
n=7 Participants
10 Participants
n=5 Participants
Marital Status
Single
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Model for End-Stage Liver Disease-Sodium (MELD-Na) Score
16 units on a scale
n=5 Participants
16.5 units on a scale
n=7 Participants
16.5 units on a scale
n=5 Participants
Etiology of Liver Disease
Alcohol
15 Participants
n=5 Participants
17 Participants
n=7 Participants
32 Participants
n=5 Participants
Etiology of Liver Disease
NASH/Cryptogenic
6 Participants
n=5 Participants
4 Participants
n=7 Participants
10 Participants
n=5 Participants
Etiology of Liver Disease
Multifactorial/Other
5 Participants
n=5 Participants
3 Participants
n=7 Participants
8 Participants
n=5 Participants

PRIMARY outcome

Timeframe: By 12 months

The proposed video intervention will be deemed feasible if at least 60% of eligible patients are enrolled in the study.

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=59 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Number of Eligible Participants Enrolled in the Study
50 Participants

SECONDARY outcome

Timeframe: Baseline and post-intervention, by 12 months

We will assess patients' knowledge of goals of care before and after the intervention using 5 true/false questions and 1 multiple choice question, each worth 1 point, for a summary score of 0 to 6 (higher score reflects greater knowledge). We have used this knowledge questionnaire in prior studies. Changes in knowledge scores from before and after the intervention will be compared between the intervention and control arms.

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=26 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
n=24 Participants
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Changes in Knowledge Scores From Baseline to Post-intervention
5.7 score on a scale
Standard Deviation 0.45
4.8 score on a scale
Standard Deviation 0.76

SECONDARY outcome

Timeframe: By 12 months

Before and after the intervention, patients will report their post-intervention preferences for life-prolonging care: life-prolonging care, limited medical care, comfort care, or unsure. Before the intervention, patients will report their preferences to receive CPR as follows: "Yes, attempt CPR", "No, do not attempt CPR", or "Not sure." Before the intervention, patients will report their preferences to receive intubation as follows: "Yes, attempt intubation", "No, do not attempt intubation", or "Not sure." Post-intervention preferences for life-prolonging care (life-prolonging care, limited medical care, and comfort care), preferences to receive CPR, and preferences to receive intubation will be compared between the two groups.

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=26 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
n=24 Participants
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Preferences for Life-prolonging Care, Preferences to Receive Cardiopulmonary Resuscitation (CPR), and Preferences to Receive Intubation
Post-intervention preferences for life-prolonging care
4 Participants
7 Participants
Preferences for Life-prolonging Care, Preferences to Receive Cardiopulmonary Resuscitation (CPR), and Preferences to Receive Intubation
Post-intervention preferences to receive CPR
9 Participants
15 Participants
Preferences for Life-prolonging Care, Preferences to Receive Cardiopulmonary Resuscitation (CPR), and Preferences to Receive Intubation
Post-intervention preferences to receive intubation
6 Participants
8 Participants

SECONDARY outcome

Timeframe: By 12 months

Population: Data not collected due to lack of access to outside hospital electronic medical records to confirm code status documentation

Code status documentation in the electronic health record will be compared between the intervention and control arms.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: By 12 months

Population: Patients randomized to the Advanced Care Planning Video Decision Support Tool intervention arm

For the video intervention arm alone, we will administer 3-items assessing patients' comfort with watching the video, whether they find the video helpful in their understanding of the EOL care options, and whether they would recommend it to others. For the outcome of "comfort" we asked patients whether they felt comfortable watching the video by asking the question: "Did you feel comfortable seeing the video in order to help you answer the questions regarding medical care?". Response choices were on a Likert scale with answer choices as follows: 1) very comfortable; 2) somewhat comfortable; 3) not comfortable; 4) don't know. We report below the percentage of patients who answered "very comfortable".

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=26 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Number of Participants Who Answered That They Felt "Very Comfortable" Seeing the Video in Response to First Question of Acceptability Questionnaire (Acceptability - Comfort)
21 Participants

SECONDARY outcome

Timeframe: Within 12 months

For the video intervention arm alone, we will administer 3-items assessing patients' comfort with watching the video, whether they find the video helpful in their understanding of the EOL care options, and whether they would recommend it to others. For the outcome of "helpful" we asked patients whether they felt the video was helpful by asking the question: "Was the video helpful in improving your understanding about your choices for medical care?". Response choices were on a Likert scale with answer choices as follows: 1) very helpful; 2) somewhat helpful; 3) a little helpful; 4) not helpful. We report below the percentage of patients who answered "very helpful".

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=26 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Number of Participants Who Answered That They Felt the Video Was "Very Helpful" in Response to Second Question of Acceptability Questionnaire (Acceptability - Helpful)
19 Participants

SECONDARY outcome

Timeframe: within 12 months

For the video intervention arm alone, we will administer 3-items assessing patients' comfort with watching the video, whether they find the video helpful in their understanding of the EOL care options, and whether they would recommend it to others. For the outcome of "recommend to others" we asked patients whether they would recommend the video to other patients by asking the question: "Would you recommend the video to other patients with advanced liver disease who are facing a similar decision?". Response choices were on a Likert scale with answer choices as follows: 1) I would definitely recommend it; 2) I would probably recommend it; 3) I would probably not recommend it; 4) I would definitely not recommend it. We report below the percentage of patients who answered "I would definitely recommend it".

Outcome measures

Outcome measures
Measure
Patients Approached for Enrollment Into the Study
n=26 Participants
We pre-specified the ACP video intervention as feasible if at least 60% of eligible patients enrolled in the study.
Verbal Narrative Control
Immediately after completing baseline assessments and randomization, patients assigned to the verbal narrative control arm will listen to the same description of the 3 goals of care used in the video arm read out by a research assistant Verbal Narrative: Verbal description of end of life care options
Number of Participants Who Answered That They Would "Definitely Recommend" the Video to Other Patients in Response to Third Question on Acceptability Questionnaire (Acceptability - Recommend to Others)
24 Participants

Adverse Events

Advanced Care Planning Video Decision Support Tool

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Verbal Narrative Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Nneka Ufere

Massachusetts General Hospital

Phone: 617-643-3408

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place